Loading...

Eli Lilly's Future Growth Driven by Tirzepatide and Favorable Market Conditions

Published
19 Sep 25
n/a
n/a
eat_dis_watermelon's Fair Value
n/a
Loading
1Y
11.2%
7D
7.1%

Author's Valuation

US$1.19k22.3% undervalued intrinsic discount

eat_dis_watermelon's Fair Value